Navicixizumab
Product Specifications
CAS Number
1638338-43-8
Target
Gamma-secretase
Related Pathways
Stem Cells, Neuroscience, Proteases/Proteasome
Bioactivity
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody that can be combined with Paclitaxel for cancer research, particularly in studies of ovarian, primary peritoneal, or fallopian tube cancer [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7195272 Inquire
Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) RHF1A Polyclonal Antibody
Sign In for Pricing
View Details 
MR223223L3V 200 µL
Tbx15 (NM_009323) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 